PubMed ID:
19523535
Public Release Type:
Journal
Publication Year: 2009
Affiliation: Division of Gastroenterology, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
DOI:
https://doi.org/10.1016/j.cgh.2009.05.033
Authors:
Hoofnagle J,
Vuppalanchi R,
Chalasani N,
Kleiner D,
Abdelmalek M,
Abrams S,
Arceo D,
Bambha K,
Barlow S,
Bass NM,
Behling C,
Belt P,
Bhimalli P,
Boyett S,
Brancati F,
Bringman D,
Brunt E,
Bryan D,
Celedon M,
Clark J,
Clark L,
Coffey M,
Colvin R,
Contos MJ,
Contos MJ,
Cummings OW,
Dasarathy S,
Dasarathy S,
Diehl AM,
Donithan M,
Doo E,
Durelle J,
Edwards K,
Espinosa D,
Everhart J,
Fairly L,
Ferrell LD,
Filipowski D,
Fuchs M,
Gottfried M,
Graham M,
Grave GD,
Green M,
Guy C,
Gyurkey G,
Hassanein T,
Hawkins C,
Hoffmann J,
Hollick R,
Huang TT,
Isaacson M,
Jones A,
Killenberg P,
Kim W,
King D,
Klipsch A,
Kowdley KV,
Kwan S,
Lavine JE,
Lee L,
Liu YC,
Luketic VA,
Lydecker A,
Lydecker A,
McCullough A,
McCullough A,
Mendoza S,
Merriman R,
Miriel L,
Mohan P,
Molleston J,
Mooney J,
Murray K,
Murray K,
Nair K,
Nash Clinical Research Network,
Nelson J,
Pabst M,
Pan YP,
Piercy D,
Ragozzino L,
Roberts S,
Robuck PR,
Rogers N,
Rosenthal M,
Rosenthal P,
Sandhu B,
Sanyal AJ,
Sanyal AJ,
Sargeant C,
Sargent R,
Saunders C,
Scheimann A,
Schwimmer JB,
Seeff L,
Selph K,
Shah AG,
Siegner J,
Sirlin C,
Smith M,
Stager M,
Stead A,
Steel T,
Stein T,
Sternberg A,
Stewart S,
Subbarao G,
Tetri BA,
Tetri BN,
Thompson J,
Tobin A,
Tonascia J,
Torbenson M,
Unalp-Arida A,
Van Natta M,
Wang C,
White M,
Wilson L,
Yates K,
Yeh M,
Young M
Studies:
Nonalcoholic Steatohepatitis Clinical Research Network
There is a need for a reliable and inexpensive noninvasive marker of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). We compared the performance of the FIB4 index (based on age, aspartate aminotransferase [AST] and alanine aminotransferase [ALT] levels, and platelet counts) with 6 other non-invasive markers of fibrosis in patients with NAFLD.